PTC Therapeutics (PTCT) Stock Price Down 11% – Baseball Daily News

This post was originally published on this site

PTC Therapeutics (PTCT) Stock Price Down 11%
Baseball Daily News
A number of research analysts have recently issued reports on the stock. Credit Suisse Group set a $55.00 price objective on shares of PTC Therapeutics and gave the stock a “buy” rating in a research report on Wednesday. ValuEngine raised shares of PTC …

and more »

This post was originally published on *this site*